When I set out to produce a QUEST story on the latest research on the causes of childhood asthma, I didn't expect to discover how little researchers know about this question. They do understand the ...
- Once-daily Enerzair® Breezhaler® (QVM149; IND/GLY/MF) met primary endpoint, demonstrating non-inferiority to a free combination of twice-daily Sal/Flu plus once-daily Tio in improving quality of ...
- Enerzair® Breezhaler® (QVM149) is a once-daily, potential first-in-class inhaled LABA/LAMA/ICS combination for asthma patients in the EU TOKYO and LONDON, May 1, 2020 /PRNewswire/ -- Sosei Group ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results